Navigation Links
Biotech Firms Receive Orphan Drug Designations, Release Clinical Data, Achieve Goals, Enter Acquisitions & Forecast Revenues - Research Report on Aegerion, Oncolytics, Merrimack, Sangamo, and PDL
Date:9/12/2013

NEW YORK, September 12, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

Today, Investors' Reports announced new research reports highlighting Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR), Oncolytics Biotech, Inc. (NASDAQ: ONCY), Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK), Sangamo BioSciences, Inc. (NASDAQ: SGMO), and PDL BioPharma, Inc. (NASDAQ: PDLI). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Aegerion Pharmaceuticals, Inc. Research Report

On September 8, 2013, Aegerion Pharmaceuticals, Inc. (Aegerion) announced that it has received orphan drug designation from Japan's Ministry of Labour, Health and Welfare for lomitapide which is used in the treatment of homozygous familial hypercholesterolemia (HoFH). The Company informed that it is currently conducting a pharmacokinetic/pharmacodynamics (PK/PD) study of lomitapide required by the Japanese regulatory authorities and expects the study to be completed in Q4 2013. Post the completion of the study, the Company also plans to conduct a small therapeutic study of lomitapide in Japanese adult HoFH patients. The Full Research Report on Aegerion Pharmaceuticals, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-09-09/AEGR]

--

Oncolytics Biotech, Inc. Resear
'/>"/>

SOURCE Investors' Reports
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
2. Puma Biotechnology Announces Completion of Private Placement
3. Animal Biotechnology - Technologies, Markets and Companies
4. AtheroNova and Maxwell Biotech Group Ratify Agreement to Develop New Atherosclerosis Drug
5. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
6. Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765
7. Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
8. Metamark Genetics Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech
9. SuperNova Diagnostics® to Present at Biotech Showcase™ 2012 During JP Morgan Healthcare Conference January 9 - 12
10. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
11. Selexis SA to Present at Biotech Showcase 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... CIRTEC Medical Systems’ Board of Directors ... of CIRTEC. , “I am delighted to be ... noted Brian Highley. “The company has made great strides ... growth over the past two years. The goal now ... and expand the services Cirtec offers its medical device ...
(Date:9/16/2014)... Ky. , Sept. 16, 2014  LABSCO, ... technologies and products to hospitals, physician office laboratories ... that, effective October 1, 2014, it will serve ... specified hospital market segments and as a semi-exclusive ... the 48 contiguous United States ...
(Date:9/16/2014)... According to Jeff Howell, Partner of Nidea Corporate ... development in Downtown Toronto is expanding at a blistering ... storeys of new development last week (including three new ... the Toronto skyline for the foreseeable future in a ... new development. , As the Toronto city council met ...
(Date:9/15/2014)... 15, 2014 EnGeneIC, Ltd. , ... treatment of cancer through the targeted delivery of ... together with the Asbestos Disease Research Institute (ADRI), ... South Wales (NSW) Premier,s Award for Excellence in ... the hospitals that will be involved in the ...
Breaking Biology Technology:LABSCO Secures Alliance With Siemens Healthcare Diagnostics 2LABSCO Secures Alliance With Siemens Healthcare Diagnostics 3ITRA Global Reports Downtown Toronto Real Estate Development is in High Gear 2ITRA Global Reports Downtown Toronto Real Estate Development is in High Gear 3EnGeneIC Named a Recipient of the Cancer Institute NSW Premier's Award for Excellence in Translational Cancer Research 2EnGeneIC Named a Recipient of the Cancer Institute NSW Premier's Award for Excellence in Translational Cancer Research 3
... study, only 25 percent of online marketers track their ... at the Jupitermedias 2004 Search Engine Strategies Conference in ... who create pay-per-click campaigns set them up and let ... ,According to the study, active online marketers often track ...
... Inc., can continue to sell advertising to competitors of ... ads, a federal district court in Virginia has ruled. ... and lucrative part of Googles business. In the third ... came from keyword advertising, also called sponsored links. ...
... about using biomass and enzymes to produce hydrogen fuel, ... Badger AgVest in Lake Delton last Thursday. ... brought to the conference by the AgVest group, which ... doesn't make specific recommendations, AgVest tries to hook up ...
Cached Biology Technology:How to make pay-per-click ad campaigns pay off 2Google wins first battle in trademark war 2Investors hear about new agricultural technology 2
(Date:9/16/2014)... the "molecular brakes" that time the generation of important ... "hair cells" translate sound waves into electrical signals that ... sounds. If the arrangement of the cells is disordered, ... research will be published in The Journal of ... and Hey2 act as brakes to prevent hair cell ...
(Date:9/16/2014)... we inherit certain traits from our parents that are ... genes play out by taking certain drugs or better ... a team of researchers at the Boston University School ... epigenetics research. , Epigenetics regulates gene expression in ... proteins, which prevent permanent mutations or alterations within the ...
(Date:9/16/2014)... has its own bacterial identity. That,s the conclusion of ... who studied the genetic fingerprints of bacteria on 57 ... "This study demonstrates for the first time that host ... strategies possess very different microbial communities on their leaves," ... researcher in the UO,s Institute of Ecology and Evolution ...
Breaking Biology News(10 mins):Hey1 and Hey2 ensure inner ear 'hair cells' are made at the right time, in the right place 2Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse? 2Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse? 3Microbiome research shows each tree species has a unique bacterial identity 2
... The ongoing dance between a virus and ... human adenoviruses typically cause mild infections, recent reports have ... fatal, human infections. Researchers from the Massachusetts ... for Public Health, School of Systems Biology, George Mason ...
... balls that can zap pain and lung tumors to ... physicians will present the latest research on cutting-edge treatments ... Meeting April 13󈝾 at the Ernest N. Morial Convention ... the theme "IR Reaching Out" and delivers education, resources ...
... have identified a new potential therapeutic target for lowering ... to statins. Scientists in the lab of ... action of a gene responsible for transporting a protein ... remove cholesterol from the blood in mice. Trapping the ...
Cached Biology News:Society of Interventional Radiology: 38th Annual Scientific Meeting 2U-M researchers find new way to clear cholesterol from the blood 2
... in-house demand is causing shortages in your ... This can cause unwanted distractions, problems and ... royalties for your hard work and endeavour! ... build it up,and market it internationally. We ...
Topoisomerase I...
...
... vaccinia virus is a type I eukaryotic ... superhelical turns (also called right- and left-handed ... of the reaction is a covalently closed, ... superhelical turns. DNA Topoisomerase I does not ...
Biology Products: